Novo Nordisk Outlines Likely COVID-19 Crisis Trial Impacts
Group Heralds Semaglutide’s Positive Phase II NASH Outcome
Novo Nordisk said late stage clinical trials near completion would not be hit by the pandemic but that delays to other stage studies were likely, and new ones were now “on hold.”
